Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis

doi:10.1016/j.jinf.2016.05.005

Comment

. 2016 Aug;73(2):174-5.

doi: 10.1016/j.jinf.2016.05.005. Epub 2016 Jun 3.

Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis

Fiona McGill¹, Robert S Heyderman², Tom Solomon³

Affiliations

¹ Institute of Infection and Global Health, University of Liverpool, UK; National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, UK. Electronic address: fmcgill@liv.ac.uk.
² Division of Infection & Immunity, University College London, UK.
³ Institute of Infection and Global Health, University of Liverpool, UK; National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, UK; Walton Centre NHS Foundation Trust, Liverpool, UK.

PMID: 27268026
DOI: 10.1016/j.jinf.2016.05.005

Comment

Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis

Fiona McGill et al. J Infect. 2016 Aug.

. 2016 Aug;73(2):174-5.

doi: 10.1016/j.jinf.2016.05.005. Epub 2016 Jun 3.

Authors

Fiona McGill¹, Robert S Heyderman², Tom Solomon³

Affiliations

¹ Institute of Infection and Global Health, University of Liverpool, UK; National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, UK. Electronic address: fmcgill@liv.ac.uk.
² Division of Infection & Immunity, University College London, UK.
³ Institute of Infection and Global Health, University of Liverpool, UK; National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, UK; Walton Centre NHS Foundation Trust, Liverpool, UK.

PMID: 27268026
DOI: 10.1016/j.jinf.2016.05.005

No abstract available

Comment on

The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults.
McGill F, Heyderman RS, Michael BD, Defres S, Beeching NJ, Borrow R, Glennie L, Gaillemin O, Wyncoll D, Kaczmarski E, Nadel S, Thwaites G, Cohen J, Davies NW, Miller A, Rhodes A, Read RC, Solomon T. McGill F, et al. J Infect. 2016 Apr;72(4):405-38. doi: 10.1016/j.jinf.2016.01.007. Epub 2016 Feb 2. J Infect. 2016. PMID: 26845731
Moxifloxacin should not be discounted in the treatment of bacterial meningitis.
Baxter M, Jacobson K, Albur M. Baxter M, et al. J Infect. 2016 Aug;73(2):173-4. doi: 10.1016/j.jinf.2016.05.009. Epub 2016 Jun 9. J Infect. 2016. PMID: 27291047 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis

Affiliations

Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis

Authors

Affiliations

Comment on

Similar articles

Publication types

MeSH terms

Substances

Grant support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Publication types

MeSH terms

Substances

Related information

Grant support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical